Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 3, 1999
Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study
L Dubertret, M Murrieta Aguttes, J Tonet
European Annals of Allergy and Clinical Immunology
|
November 13, 2020
Allergic rhinits: impact on quality of life of adolescents
C S Rosario, M Murrieta-Aguttes, N A Rosario
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
August 3, 2000
Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine
L Michel, M Murrieta-Aguttes, F Jean-Louis, et al.
The Journal of International Medical Research
|
March 22, 2000
Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis. Riperex Study Group
G K Scadding, A J Tasman, M Murrieta-Aguttes, et al.
Allergy
|
June 26, 2001
Mizolastine in the treatment of seasonal allergic rhinoconjunctivitis: a European clinical experience with 5408 patients managed in daily practice (PANEOS SAR Study)
C Bachert, V Vovolis, P Margari, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 6, 2000
One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group
G Lorette, A Giannetti, R S Pereira, et al.
The Journal of International Medical Research
|
July 10, 1999
Rapid and sustained efficacy of mizolastine 10 mg once daily in seasonal allergic rhinitis
M Stern, P Blondin-Ertzbischoff, M Murrieta-Aguttes, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
January 1, 1991
Systemic allergic reactions to corticosteroids
M Murrieta-Aguttes, V Michelen, F Leynadier, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 3, 1999
Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study
L Dubertret, M Murrieta Aguttes, J Tonet
European Annals of Allergy and Clinical Immunology
|
November 13, 2020
Allergic rhinits: impact on quality of life of adolescents
C S Rosario, M Murrieta-Aguttes, N A Rosario
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
August 3, 2000
Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine
L Michel, M Murrieta-Aguttes, F Jean-Louis, et al.
The Journal of International Medical Research
|
March 22, 2000
Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis. Riperex Study Group
G K Scadding, A J Tasman, M Murrieta-Aguttes, et al.
Allergy
|
June 26, 2001
Mizolastine in the treatment of seasonal allergic rhinoconjunctivitis: a European clinical experience with 5408 patients managed in daily practice (PANEOS SAR Study)
C Bachert, V Vovolis, P Margari, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 6, 2000
One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group
G Lorette, A Giannetti, R S Pereira, et al.
The Journal of International Medical Research
|
July 10, 1999
Rapid and sustained efficacy of mizolastine 10 mg once daily in seasonal allergic rhinitis
M Stern, P Blondin-Ertzbischoff, M Murrieta-Aguttes, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
January 1, 1991
Systemic allergic reactions to corticosteroids
M Murrieta-Aguttes, V Michelen, F Leynadier, et al.
Page
of 1